Bioalpha MD visited tan Sri wahid office in pnb, some excited news is coming soon????

according to latest sinchew news as link posted above
once the hydropower plant in DOn Saho completed , will produce 2000 gigawatt per year
which is equal to 2000000000 kilowatt , which will ensure rm500 million revenue yearly , as stated by director

i had google the local laos tariff , which is around 350 kip per kilowatt per hour
which 2000000000kw x 350 kip = rm 300-400million ( i use to lowest average electrical tariff in laos , u all can just google this info )

from the 2016 annual report , the PBT for power section is around 22% ( minus off the construction profit from don saho project )
lets assume the revenue from don saho will be rm500million , x 22% = around rm100million PBT

so after all , is this Don Saho project still alluring as stated by public invest house ?
with current power section from china and tawau plant , MFCB already achieve close to rm100million PBT in his power section (to be exact , around Rm80million for finanical year 2016 )

so after all , MFCB is merely replacing their china and tawau sector with this don saho hydro power plant

the most profitable sector is still their resources sector

we can see in latest announcement company also intend to diversify into ???? coconut planting business ( er = =!!! )

so will this don saho project contribute double or trifold in company profit ? ..... after all i dont think so


above is just my humble opinion and calculation
correct me if i am wrong :)

It's bad sign for it to ding don't daily
Technical chart show doji star which means buyer and seller is still fighting

E-constant penetrate into Pdrm
Source from constant fb

Let's hope it can be as good as hai-o

1 men poison is another men meat
its good some negative comment flowing in
do your own research not blindly follow others

http://wesharenwetrade.blogspot.my/2017/06/biohldg0179.html

A company eligible for main board listing also show that the particular counter is more strong fundamental

adui .... boy boy i hope you know that many fund manager out there are not allow to buy counter in ace market
even got fund buying in they got certain limit only cant buy much

so once company announce transfering to main board u can see the share price shoot up
then once in mainboard easier for price to go higher with support of fund

now tell me main board listing is not important

But according to the busy weekly interview, mikromb director have No intention to get transfer to main board
Maybe this year agm can go and clarify reason behind

But conclusion the share price and eps will get diluted so what's the difference
For me ntg to shout about bonus / split
I am. More excited if mikromb announce transfer to main board

Constant **

Ya management stated during agm
Contact expanding with franchise mode
Won't impact on balance sheet

Constant is planning to expanding into Vietnam

http://www.klsescreener.com/v2/news/view/239907

Ya long term player is strong in this counter
I was actually queue at 0.2
But who knows the support level at 0.22
Now rebound to 0.23
Contra player are washing out

My average price is 0.24
Top up a lot during 0.26 after agm.... Sigh

1 more month before q2 closing account

1 thing about this company is you can keep track the progress on facebook
seldom see other listed company do so
example , bioalpha have personal facebook page and just awarded with Mesti cert

Thanks Jesus for uptrend :)

Yes no need sorry
Mine also around 10k loss
This is no buy sell call
Do ur own homework
I added some at 0.22 again today

Yes Mr William do mention this quarter will better then last year
I am not the only 1 who heard this, there are around 10-20+ people there too
I myself enter more share at 0.26 after agm
So I am victim too

Depends on how u view the qr
For me I saw chances

My tp 0.2
My bullet is ready xD

Director not only tipu me but he tipu all the people around also

I mean from his point of view result actually Is better than q12016
Increase revenue all sector and excluded 1 off expenses actually you pat increase
He do mention 1 off expenses to us
I myself enter more at 0.26 after agm but I don't feel that I got cheated

This is only q1 2017 and more will come without 1 off expenses

Revenue from all sector increases
Its the administrative expenses killing the bottom line
There is 1 off expenses as mention before
it's a long term stock will continue collect if tomorrow down

Minus off administrative expenses, actually the result improve you
But I can't deny tomorrow will be dropping like he'll

Judging the price movement
My bet today qr will release

@sc agm held in hotel bangi putrajaya

Game over

Mr willaim is a very humble person
answer all shareholder question patiently
very glad i am able to attend this year AGM
advise all shareholder to attend next year AGM to judge urself

just to add on what MD Mr William say during AGM
according to him , demand for herbal is encouraging
they are now more focus on value added product
for example , dry form of katchip fathimah may sell for rm100 , but if they process it into ready to consume form they can sell higher price ( this show how efficient management is trying to increase return for shareholder )

as mention , doing phase 2 land cleaning

they have now focus on 2 major clinical trial

1st is traditional medication in controlling type 2 diabetes mellitus

just for u all know , Type 2 diabetis mellitis is a chronic disease with no cure , only prevention and control the disease
in other word , once u diagnose with T2DM , it will be with u until u die
current treatment for T2DM is only insulin injection , oral hypoglycemic agent and dietary control

Mr william added that the trial for traditional medication in T2DM is very encouraging
in just 3 years time they will have clinical trial in local hospital


so far in medical segment , there is very very few proven supplement / product will help in control blood glucose
what I can say is almost none !
dont ask how i know , cuz I am working in KKM
if this clinical trial successful , u can imagine how big is this business and the future is very bright as T2DM is worldwide chronic disease
which bring alot of complication if blood sugar is deranged

2nd major clinical trial is traditional medication as a hormone replacement therapy for menopausal women
some Post-menopausal symptoms eg flushing , body ache , agitation is common after women achieve menopause because of the imbalance of hormone supply
Mr William added , their study had prove trad medication effective in increase estrogen level and play a role as hormone replacement therapy

in current market , to treat post menopausal symptoms we usually supply hormone replacement therapy eg estrogen to ease the symptoms of post menopausal
this have bring alot of un-neccesary complication eg thrombosis , uterine cancer

hope this new traditional medication by bioalpha aided as natural source of
estrogen replacement which reduce unwanted side effect of current hormone replacement therapy


for oversea market
Mr william say will focus more on China market
according to him , very huge potential
they are not even fully export to whole west china ( this is very important)
in this year ,they had just open up inner mongolia market ( good news as company very aggresive in expanding market )

for constant
17 outlet now
almost every month there is a new outlet opening
( he bring up example of opening bangi branch recently and 2 more branch to
be open soon as mention in annual report )

target 30 outlet of constant end of the year

they have just sign 20k of co-op member for ECONSTANT
member / agent of econstant currently included PDRM
He do make joke that dont be suprise next time if u see police officer selling bioalpha product to you :)

for those worry why indonesia market dropping
this is because they facing lenghty product registration time
with new factory opening , they had shorten the product registration time
and they had obtain indonesia license recently ( call ?ukut ) to produce product like coffee , drink , powder form , sachet , liquid , capsule ( but not tablet form )

5 product so far in indonesia market and will be more in indonesia in future


aim to have 100 constant pharmacy outlet in whole malaysia to control all upstream , downstream and all retail market in pharmacy malaysia ( on par of caring )


above is not a buy / sell call
do analyse urself to value this company worth to hold or not

Yes agree
Result not good, but satisfactory
Tomorrow share price will drop

IMHO
Even William give word 1st quarter will be better than last year
But don't give too much hope on the Q1
He do mention there is 1 off expenses ( ESOS)
Pls do some research before any buy / sell

continue update

beside question we asked

there is slide show presentation by company to explain background and future plan
quite detail i would say

share price had up 125% since IPO
bioalpha involving both up and down stream , phase 2 land cleaning is ongoing
when mature , able to produce 440 metric tone of herbal per year

for health product , nushine is higher end
in indonesia is call alpha health
new brand such as surya had been introduced

company just introduce carica papaya leaf in dengue
company mention this product can increase platelet count in dengue patient
research done by IMR proven
there is another shareholder giving feedback carica papaya leaf product by bioalpha is very nice to consume ( company explain because they added lemon and apple inside )

regarding pharmacy retail
currently there is total 17 outlet
14 in klang valley
company feel klang valley is very competitive
so will more focus on area outside klang valley
for example , Tanah Merah branch is doing very well

in next 18 month , will introduce next 12 product

for indonesia outlook
previously very difficult in register new product in indonesia
now since they had acquired new factory , can shorten the register period and can even manufacture new product from indonesia factory soon
CAGR of indonesia in past 5 years is around 30%


for china outlook
only export to china since 2 years ago
CAGR of 546% in 2 year for china market
they had done alot of roadshow and exhibition to china
will introduce 5 new product to china market this year

in malaysia market
will introduce 10 more new product this year
herbal is harvested by 2020
as mention , aim to have 30 pharmacy this year and will expand outside klang valley
wont impact balance sheet much because they expand pharmacy through francise mode

E-constant
agent able to sale around 5000 product through online
able to earn commision
target 20000 member in e-constant

forget to mention
this come out from william mouth

THIS YEAR Q1 WILL BE BETTER THEN LAST YEAR Q1
( but there is 1 off expenses in q1 2017 due to ESOS )

so wait what guys ?? buy now lo !!

rest i will update later , very tired wan rest awhile

other question we asked during off table

1) why other director keep selling share ??
make our shareholder very panic and scare

answer : they also want to get back some money
some director are alloted with large ESOS ( from 100k to 500k )
they cant forge out large money in investment like us
so they sell share for money , not becuase company not good

2) factory utilization rate ?
65%

3) indonesia political unstable ??
issue will always be there , this 1 company cant controlled

4) who is the main competitor
small farmer that owned 1-2ekar
small farmer dont have factory and no goverment backup so no need worry
other similar business model will be eg HOVID , YSP

5) what is the best selling product ?
tongkat ali in export market
chlorophyll in local market ( malaysia )

6) administractive expenses is high , why
administractive high because of rebranding , refrubrish pharmacy
and also included grant from goverment for support
in future will reduce

7) indonesia market dropping , why ??
dont worry , because only have 5 product so far and can achieve such great achivement
will introduce more new product in future

8) 1 of shareholder asking about e-constant
- just introduce 2 weeks ago
something like HAIO , but not MLM
cuz e-constant is like single tier
currently target more retired civil servant to register as agent
director say aiming e-constant to be as good as HAIO

9) another shareholder asking about land bank
clearing up phase 2 in desaru
but terranganu land bank utilization rate higher due to better infrastructure and better
goverment support
goverment support around rm20million in terrangganu planting site
by 3 years time , land bank will be 100% utilise

10) binexus tax extempted status ?
will be expired by jun2018 , but renewable
comapny will shift business to terrangganu after this and get another 10 years tax extempted
status ( expired 2027 )

11) any more right issue in future?
in next 2 years no more
last right issue still haven fully utilise

12) any more new herbs planting since there is 100 ++ trad meds around in malaysia ?
company will next focus on black pepper , white pepper , kunyit
they have large demand from a single big customer so they chasing the supply now

13) another share holder worry last year china sales might be 1 off sales
Mr william reply
dont worry , large demand continuous flow through from china
they just sign sales from yun nan market
and recently open up inner mongolian market
demand from china is huge
they will visit china every 2 month to do road show / exhibition to promote the product

14) pharmacy net profit margin and revenue contribution ?
net profit margin around 25% , each outlet contribute around rm1million in revenue

update from AGM

during asking question

1) why PNS are selling 18million share on 18/4/17
Dato Rosley reply : its the PNS policy to sells or buy share or certain time
PNS is a GLC company and its common to buy and sell share at certain
time
why so worry since PNS still holding 11% of share
member of PNS had meeting last night and had agree to buy more and
more in future .
Bioalpha is in heath sector and u cant go wrong in this sector , with
goverment back up

2) main board plan ?
already done consultation
member are working hard
there is alot things to be done , need to ask bank for advise , quotation but dont worry
member is working towards it
( no date mention this year or next year , when ask board of director say will work hard as soon
as possible , cuz if submit for transfer but at the end got rejected by SC will waste shareholder
money )

3) 1 of the share holder asking whether board of director can give 3 year forecast ?
director say very hard to forecast like this , but we are on plan on fast growing
turnover from indonesia and china is very good

4) why company have large share ( 800million ) and causing eps dilution
in 2015 they pay out 0.09cent dividen
which is too low
so director thinking shareholder will prefer rewarded with bonus issue , PLus the right issue
hence large share currently ( 800million )


5) increase of trade receivable from 19million to 29million ( 66% increment ) , why ?
40% of trade receivable had been collected back since this year
large because quarter 4 is strongest sales , so most of trace receivable increase during quarter 4
also , due to nature of competition in pharmacy , it is common to have large trade receivable
ageing 90-180 days
director mention all pharmacy chain operator will have large trace receivable ranging 90-180
days as well

6) rm5million trade receivable > 180 days , impact on cash flow issue ?
70% of trade receivable > 180 days had been collected back
company only recorded < 1% of bad debt in 2016
so rest assure no impact in cash flow
director william ask to wait for Q1 2017 so that we can analyse and see ourself that trace
receivable had been collected back

7) during ipo , company mention will team up with fathimah and expand into UAE , any update ?
due to slow nature business of fathimah group of company , company had cancel the plan
to team up with fathimah
but company are eyeing new partner and will expand into middle east market
will make announce once new partner target
company mention never give up in expanding middle east

Agm finish
Wait for my update
I am more confident
Very positive and a lot good news from agm

Free health screening ( basically a blood pressure monitoring and capillary sugar checking)
Breakfast
Test drink of apple cider vinegar

Free gift worth of rm200
Can choose either tongkat Ali or collagen ( male / female)

They have booth showcase all their product and a small brochure explaining their product

They took chance to introduce e constant too

Very generous management
Around 200 worth of door gift

Large drop today

I feel very grateful share price is very solid despite bad market sentiment

I am going to agm and will enquire more regarding receivable
Wait for my update here :)

Another esos today

yes u are right
i wont know qr is good or bad unless i am insider
so in my statement i put "opinion"
and i support my "opinion" after i read all the Qr and AR , and i know they have large administrative fees which use in rebranding constant and acquire constant late january 2016
which , if able to reduce those cost this qr , profit will show increase compare yoy

unless u owned I3investor , i dont see why i have no right to give my opinion here
ur comment is rather rude

i am not big shark of course i use the work " I think " lo .... LMAO
u understand what is "I think' or not ???

i dont understand W*F u mad towards my comment

u r the 1 shouldn't put personal feeling

if QR bad ...... easy , sell la
i wait for u to tell me what to do meh

See I told d
Biohldg chart is nice
Contra player don't have such power or money to fly up the volume / price
This big shark is very scary
I think they waiting for qr

I have different opinion
Previously qr low are mainly low contribution from constant ( they acquire constant only on Jan 2016), after that they spend a lot money in rebounding and renovate old constant
And hence the low profit
Now constant is more mature compare to last year
I am not surprised it might be as good as last qr
From Facebook also can see they very active doing promotion to boost up constant sales

Aiyo why so worry about this company
I can tell u this q1 confirm will be good
Look at chart also know
Big volume again with price surge
Insider are collecting before quarter release
So obvious hint already

WAKAKAKAKA
yes sir i am not buying
ur money ur choice
eps 0.49 give dividen 1.8 ....
wakakaka
i guess the remaining 1.3 sen cash for dividen just drop from sky

FLBHD last year have larger forex loss
if minus off forex exchange factor , yoy doesn't improve much

qoq revenue drop
assuming whole year eps 2 ..... pe will be 20

negative cash flow
net debt company

company just raise fund from ipo and shouldn't really pay out so much dividen
in fact for me growth company should never pay dividen if not whats the use for ipo fund raising ??

this is just wasting shareholder fund !!

omg ah boon and investquan is here !!!
taikor level investor is supporting this counter
more hope in this counter :)